Biologic-device reconstitution and delivery device stability

A biotech manufacturer sought Chimera’s advice on assessing stability parameters of the diluent chamber of a two chamber liquid-dry reconstitution cartridge containing a lyophilized biologic. Chimera provided technical strategy, specifications and a technical approach for the separate determination of the stability of the diluent chamber, the lyo-drug chamber and the reconstituted drug solution.